Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Services
  • Locations
  • Physicians
  • Patient and Visitor Info
  • Clinical Trials
  • Event Calendar
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • HealthView Patient Login
  • Quality and Safety
Home > Physicians > Herndon, Leon W.
Jumbo Large Regular Text:
Print E-mail
Physicians

Leon W. Herndon, MD

Related Content

Video

Glaucoma Overview

Locations

  • Duke Eye Center
  • Duke Eye Center of Raleigh

Services

  • Glaucoma

Health Library

  • Best Doctors 2011-2012 Award Winners
  • Cutting Edge Surgery
  • Implanting Hope

Share

Leon W. Herndon, MD

Department / Division
Ophthalmology / Glaucoma Ophthalmology

Address
DUMC 3802
Durham, NC 27710

Appointment Telephone
919-681-3937

Fax Telephone
919-681-8267

Training
  • MD, University of North Carolina at Chapel Hill School of Medicine, 1991

Residency
  • Internal Medicine, UNC Hospitals, 1991-1992
  • Ophthalmology, UNC Hospitals, 1992-1995

Fellowship
  • Glaucoma, Duke University Medical Center, 1995-1996

Clinical Interests
Medical and surgical management of glaucoma, cataract surgery with emphasis on combined cataract and glaucoma

Research Interests
I have an interest in exploring better medical and surgical ways to treat patients and will continue to be involved in clinical trials involving novel drug-delivery systems and new surgical procedures. I also have a research interest in the differential burden of glaucoma on African-derived populations.  This question is multi-faceted, and involves a comprehensive evaluation of the genetics, economics, accessibility to treatment, and response to therapy of these populations.

Industry Relationships and Collaborations (What's this?)

This physician (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

  • Alcon Laboratories
  • Allergan, Inc.

Representative Publications
Malone PE, Herndon LW, Muir KW, Jaffe GJ. Combined Fluocinolone Acetonide Intravitreal Insertion and Glaucoma Drainage Device Placement for Chronic Uveitis and Glaucoma. Am J Ophthalmol. 2010 Feb 25. (2010) Abstract

Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL, . Three-Year Follow-up of the Tube Versus Trabeculectomy Study. Am J Ophthalmol. 2009 Aug 10. (2009) Abstract

Muir KW, Santiago-Turla C, Stinnett SS, Herndon LW, Allingham RR, Challa P, Lee PP. Glaucoma patients' trust in the physician. J Ophthalmol. 2009;2009:476726. (2009) Abstract

Stein JD, McCoy AN, Asrani S, Herndon LW, Lee PP, McKinnon SJ, Allingham RR, Challa P. Surgical management of hypotony owing to overfiltration in eyes receiving glaucoma drainage devices. J Glaucoma. 2009 Oct-Nov;18(8):638-41. (2009) Abstract

Ahmad S, Wallace DJ, Herndon LW. Phthisis after endoscopic cyclophotocoagulation. Ophthalmic Surg Lasers Imaging. 2008 Sep-Oct;39(5):407-8. (2008) Abstract

Duarte MC, Herndon LW, Gupta PK, Afshari NA. DSEK in eyes with double glaucoma tubes. Ophthalmology. 2008 Aug;115(8):1435, 1435.e1. (2008) Abstract

Gedde SJ, Herndon LW, Brandt JD, Budenz DL, Feuer WJ, Schiffman JC. Surgical complications in the Tube Versus Trabeculectomy Study during the first year of follow-up. Am J Ophthalmol. 2007 Jan;143(1):23-31. (2007) Abstract

Stein JD, Herndon LW, Brent Bond J, Challa P. Exposure of Ex-PRESS Miniature Glaucoma Devices: case series and technique for tube shunt removal. J Glaucoma. 2007 Dec;16(8):704-6. (2007) Abstract

Weizer JS, Asrani S, Stinnett SS, Herndon LW. The clinical utility of dynamic contour tonometry and ocular pulse amplitude. J Glaucoma. 2007 Dec;16(8):700-3. (2007) Abstract

Herndon LW, Brunner TM, Rollins JN. The glaucoma research foundation patient survey: patient understanding of glaucoma and its treatment. Am J Ophthalmol. 2006 Jan;141(1 Suppl):S22-7. (2006) Abstract

Herndon LW. Measuring intraocular pressure-adjustments for corneal thickness and new technologies. Curr Opin Ophthalmol. 2006 Apr;17(2):115-9. (2006) Abstract

Weizer JS, Stinnett SS, Herndon LW. Longitudinal changes in central corneal thickness and their relation to glaucoma status: an 8 year follow up study. Br J Ophthalmol. 2006 Jun;90(6):732-6. (2006) Abstract

Song J, Lee PP, Epstein DL, Stinnett SS, Herndon LW Jr, Asrani SG, Allingham RR, Challa P. High failure rate associated with 180 degrees selective laser trabeculoplasty. J Glaucoma. 2005 Oct;14(5):400-8. (2005) Abstract

Herndon LW, Weizer JS, Stinnett SS. Central corneal thickness as a risk factor for advanced glaucoma damage. Arch Ophthalmol. 2004 Jan;122(1):17-21. (2004) Abstract

Herndon LW, Challa P, Allingham RR. Glaucoma in Ghana, West Africa: clinical features and the role of mutations in Myocilin. Ophthalmol Clin North Am. 2003 Dec;16(4):631-7. (2003) Abstract

Herndon LW, Robert D Williams , Wand M, Asrani S. Increased periocular pigmentation with ocular hypotensive lipid use in African Americans. Am J Ophthalmol. 2003 May;135(5):713-5. (2003) Abstract

Herndon LW, Asrani SG, Williams GH, Challa P, Lee PP. Paradoxical intraocular pressure elevation after combined therapy with latanoprost and bimatoprost. Arch Ophthalmol. 2002 Jun;120(6):847-9. (2002) Abstract

Herndon LW, Challa P, Ababio-Danso B, Boateng JO, Broomer B, Ridenhour P, Allingham RR. Survey of glaucoma in an eye clinic in Ghana, West Africa. J Glaucoma. 2002 Oct;11(5):421-5. (2002) Abstract

Myers JS, Yang CB, Herndon LW, Allingham RR, Shields MB. Excisional bleb revision to correct overfiltration or leakage. J Glaucoma. 2000 Apr;9(2):169-73. (2000) Abstract

Myers JS, Trevisani MG, Imami N, Herndon LW, Wolbarsht ML, Allingham RR, Straub KD, Shields MB. Laser energy reaching the posterior pole during transscleral cyclophotocoagulation. Arch Ophthalmol. 1998 Apr;116(4):488-91. (1998) Abstract

Stone RT, Herndon LW, Allingham RR, Shields MB. Results of trabeculectomy with 0.3 mg/ml mitomycin C titrating exposure times based on risk factors for failure. J Glaucoma. 1998 Feb;7(1):39-44. (1998) Abstract

Choudhri SA, Herndon LW, Damji KF, Allingham RR, Shields MB. Efficacy of autologous blood injection for treating overfiltering or leaking blebs after glaucoma surgery. Am J Ophthalmol. 1997 Apr;123(4):554-5. (1997) Abstract

Herndon LW, Choudhri SA, Cox T, Damji KF, Shields MB, Allingham RR. Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes. Arch Ophthalmol. 1997 Sep;115(9):1137-41. (1997) Abstract

Yang CB, Myers JS, Herndon LW, Allingham RR, Shields MB. Rate of progression in open-angle glaucoma estimated from cross-sectional prevalence of visual field damage. Am J Ophthalmol. 1997 Mar;123(3):426-8. (1997) Abstract

Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En Español | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2012 Duke University Health System

About This Page

Updated: Oct. 27, 2010
Published: Dec. 12, 2006
URL: http://www.dukehealth.org/physicians/leon_w_herndon